This study showed that the concomitant application of tumor-derived self DNA with IGF-1R inhibitors exhibited an anti-proliferative effect, which was counteracted by the simultaneous inhibition of TLR9 signaling. The gene discussed is IGF1R; the disease is neoplasm.